Title of article :
Factors associated with adherence to treatment in Iranian patients with inflammatory bowel disease
Author/Authors :
Forouzan, Zohre Department of Gastroenterology - Alzahra hospital - Isfahan University of Medical Sciences and Pour-Sina-Hakim Research Center, Isfahan , Gholamrezaie, Ali Department of Gastroenterology - Alzahra hospital - Isfahan University of Medical Sciences and Pour-Sina-Hakim Research Center, Isfahan , Nasimi, Hasan Department of Gastroenterology - Alzahra hospital - Isfahan University of Medical Sciences and Pour-Sina-Hakim Research Center, Isfahan , Faramarzi, Mohammad Student Research Committee - Ahvaz Jondishapour University of Medical Sciences, Ahvaz, Iran , Bagheri-Ghalehsalimi, Amin Department of Gastroenterology - Alzahra hospital - Isfahan University of Medical Sciences and Pour-Sina-Hakim Research Center, Isfahan , Nourian, mohammadamin Department of Biological Science - California State University, Stanislaus, Turlock, USA , Fereidan-Esfahani, Mahboobeh Department of Gastroenterology - Alzahra hospital - Isfahan University of Medical Sciences and Pour-Sina-Hakim Research Center, Isfahan , Emami, Mohammadhasan Department of Gastroenterology - Alzahra hospital - Isfahan University of Medical Sciences and Pour-Sina-Hakim Research Center, Isfahan
Abstract :
Background: In this study, we investigated several socioeconomic, clinical, and psychological factors associated with medication
adherence in a sample of Iranian patients with inflammatory bowel disease (IBD). Materials and Methods: This study was conducted
on 110 IBD patients from 2013 to 2014 in Isfahan, Iran. The patients were invited to complete three anonymous questionnaires including
the Hospital and Anxiety Depression Scale (HADS) for assessing the levels of anxiety and depression; IBD Questionnaire‑Short
Form (IBDQ‑9) for the quality of life; and a visual analog scale assessing the medication adherence. A self‑assessment adherence
rate of more than 80% was considered “appropriate adherence.” Results: Overall, 99 patients completed the questionnaires. Among
them, 77.8% reportedly adhered to their medications. There was no statistical difference between adherence and nonadherence
rates in terms of gender, educational status, disease type, disease severity, and family history of IBD. Conversely, single patients
(100% vs. 74.1%; P = 0.03), nonsmokers (79.4% vs. 0.0%; P = 0.04), patients receiving immunosuppressive drugs (100% vs. 71.9%;
P = 0.01), and corticosteroids (95.1% vs. 65.5%; P = 0.01) were more likely to be adhered than their counterparts. No differences
emerged in terms of the mean HADS scores in either of the sexes. The mean IBDQ‑9 score was significantly higher in adhered patients
only in females (31.08 ± 11.6 vs. 24.7 ± 9.1; P = 0.04) but not in males. Conclusion: The adherence rate in our study is almost similar
to developed countries. Single marital status, not smoking, receiving corticosteroids and immunosuppressive drugs, and higher
IBDQ‑9 score in females are associated with higher adherence rate.
Keywords :
Adherence , inflammatory bowel disease , nonadherence , treatment
Journal title :
Journal of Research in Medical Sciences